Abstract
Polymers have been shown to have viable applications in the biomedical field, from controlled drug delivery systems to biological implants. The preparation and processing of polymers into bio-systems have nevertheless encountered some technical challenges in part customization and adverse effects to the human body functions and recovery. This study proposes the utilization of 3D printing technology and supercritical carbon dioxide (scCO2) processing to deliver a drug-impregnated polymeric material system which can be engineered and tuned to suit a particular implantation procedure and dramatically improve patient outcomes. In this work, an acrylate-based polymer is 3D-printed using stereolithography, then impregnated with flurbiprofen drug using scCO2. Drug loading above 24 % by mass is achievable under the tested conditions. The correlation of drug loading and material surface roughness with different process parameters, including 3D printing layer thickness, scCO2 processing temperature, pressure and treatment time, are investigated and empirically modeled using the linear regression methods.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
